SEC Company Response from Harvard Ave Acquistion Corp (HAVA, HAVAR, HAVAU) (CIK 0002042460) (HAVA) — Sep 25, 2025
Harvard Ave Acquistion Corp (HAVA, HAVAR, HAVAU) (CIK 0002042460)
Date: Sept. 25, 2025 · CIK: 0002042460 · Accession: 0001213900-25-091548
AI Filing Summary & Sentiment
File numbers found in text: 333-284826
Referenced dates: September 24, 2025
Show Raw Text
CORRESP
1
filename1.htm
Harvard Ave Acquisition Corporation
c/o Robinson & Cole LLP
Chrysler East Building
666 Third Avenue, 20th Floor
New York, NY 10017
VIA EDGAR
September 25, 2025
Benjamin Holt
Division of Corporation Finance
Office of Real Estate & Construction
U.S. Securities & Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re:
Harvard Ave Acquisition Corporation
Amendment No.3 to Registration Statement on Form S-1
Filed September 19, 2025
File No. 333-284826
Dear Mr. Holt:
Harvard Ave Acquisition Corporation
(“we” or the “Company”) hereby provides responses to the comments of the staff (the “Staff”) of the
U.S. Securities and Exchange Commission contained in the letter dated September 24, 2025, regarding the Company’s Amendment No.3
to the Registration Statement on Form S-1 referenced above (the “Registration Statement”). Contemporaneously, the Company
is filing Amendment No.4 to the Registration Statement (the “Amendment No.4”) via Edgar.
The Staff’s comments
are repeated thereafter in bold and are followed by the Company’s responses. Page references in the text of this response letter
correspond to the page numbers of Amendment No.4. Capitalized terms used but not defined herein are used herein as defined in the Amendment
No.4.
Amendment
No. 3 to Registration Statement on Form S-1 filed September 19, 2025
Description
of Securities, page 138
1.
Please revise here, and elsewhere as appropriate, to disclose the exclusive forum provision of each of your amended and restated memorandum and articles of association and the rights agreement. For example, describe the provision, including the relevant forum for litigation and any subject matter jurisdiction carve out; describe any risks or other impacts on investors; and address any uncertainty about enforceability.
Response: In response to the Staff’s comment, we have revised the disclosure on pages 46, 145, and 151 of Amendment No. 4.
Exhibits
2.
The trust account termination letter attached
as Exhibit A to the Investment Management Trust Agreement filed as Exhibit 10.2 states that "[o]n the Consummation Date (i) counsel
for the Company shall deliver to you written notification that the Business Combination has been consummated, or will be consummated substantially,
concurrently with your transfer of funds . . . ." Nasdaq Listing Rule IM-5101-2(a) states that “[a]t least 90% of the gross
proceeds . . . must be deposited in a trust account maintained by an independent trustee.” It is unclear how the release of funds
earlier than the consummation of the initial business combination would comport with this listing standard. We also note that the exhibit
is inconsistent with the disclosure in the prospectus, which states that funds in the trust account will not be released until the completion
of your initial business combination.
Please revise to address these inconsistencies.
Response: In response to the Staff’s
comment, we have revised Exhibit A to the Investment Management Trust Agreement filed as Exhibit 10.2 to Amendment No. 4 to state that
the funds in the Company’s trust account will not be released until a business combination has been consummated, or will be consummated
concurrently with the transfer of funds to the accounts as directed by the Company.
We appreciate the assistance
the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Ze’-ev D. Eiger
of Robinson & Cole LLP, at (212) 451-2907.
Very truly yours,
By:
/s/ Sung Hyuk Lee
Sung Hyuk Lee
cc:
Ze’-ev D. Eiger, Esq.
Arila E. Zhou, Esq.
Robinson & Cole LLP